Dr Reddys Laboratories has reported results for its first quarter ended June 30, 2011.
The company’s net profit for the quarter has surged by 25.38% at Rs 262.74 crore as compared to Rs 209.55 crore for the quarter ended June 30, 2010. Its net income from sales and services has increased by 17.54% to Rs 1978.32 crore for the quarter under review from Rs 1683.13 crore for the corresponding quarter of the previous year.
Dr Reddys, a global pharmaceutical company, has a global presence in more than 100 countries, with subsidiaries in the US, UK, Russia, Germany and Brazil; joint ventures in China, South Africa and Australia; representative offices in 16 countries and third-party distribution set ups in 21 countries.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1515.00 |
Dr. Reddys Lab | 6080.25 |
Cipla | 1565.50 |
Zydus Lifesciences | 1110.95 |
Lupin | 1601.00 |
View more.. |